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ABSTRACT 
Aim: Lichen planus is a lymphocytic inflammatory disorder of unknown 
origin mediated by cellular immunity. The reports documenting contact 
hypersensitivity to certain antigens are increasing in number mainly in 
oral but also in cutaneous lichen planus as well. However, there are only a 
few studies questioning whether there is any alteration in contact hyper-
sensitivity response in this patient group due to T-cell mediated changes. 
Methods: The purpose of this study is to find out the prevalence of contact 
hypersensitivity to standard contact allergens in cutaneous lichen planus 
patients. In the present study 43 cutaneous lichen planus patients and 33 
controls were patch tested by T.R.U.E test methodology. 
Resulst: A positive patch test reaction was found in 11.6% of the lichen 
planus patients while the control group showed a percentage of 30.3%. 
Statistically, the difference between the two groups was not significant 
(Fischer test p=0.07). 
Conclusions: This is the first study examining into the standard patch test 
positivity in cutaneous lichen planus patients the results showed no dif-
ference from the control.
Key words: contact hypersensitivity; lichen planus; cutaneous lichen planus; 
patch test; T.R.U.E. test
KÜTANÖZ LIKEN PLANUSTA STANDART KONTAKT ALLERJENLERE AŞIRI 
DUYARLILIK
ÖZET
Amaç: Liken planus, lenfositik enflamasyonla karakterize hücresel immün siste-
min rol oynadığı nedeni bilinmeyen bir hastalıktır. Belirli antijenlere karşı kon-
takt aşırı duyarlılığın başta oral liken planus olmak üzere kütanöz liken planusta 
da bulunduğunu gösteren çalışmalar giderek artmaktadır. Buna karşın T hücre 
aracılı bu hastalıkta kontakt aşırı duyarlılık cevabında herhangi bir değişiklik 
olup olmadığını sorgulayan az sayıda çalışma mevcuttur. 
Hastalar ve Yöntem: Bu çalışmanın amacı kütanöz liken planuslu hastalarda 
standart kontakt allerjenlere karşı oluşan aşırı duyarlılık reaksiyonlarının 
prevalansını saptamaktır. Bu çalışmada kütanöz liken planus tanısı konulan 
43 kişilik hasta grubuna ve 33 kişilik kontrol grubuna T.R.U.E test metolojisi 
ile yama testi uygulanmıştır. 
Bulgular: Hasta grubunda yama testi pozitifliği %11.6, kontrol grubunda 
%30.3 olarak bulunmuştur. İki grup arasındaki fark istatistiki olarak anlamlı 
değildir. (Fischer testi p=0.07). 
Sonuç: Bu çalışma kütanöz liken planusta yama testi pozitifliğini araştıran 
ilk çalışmadır ve hasta grubunun kontrol grubundan farklı olmadığı sonu-
cuna varılmıştır.
Anahtar sözcükler: kontakt aşırı duyarlılık, liken planus, kütanöz liken planus, 
yama testi, T.R.U.E test
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Introduction
Lichen planus (LP) is an inflammatory dermatosis of skin 
and mucous membranes characterized by flat-topped, vio-
laceous, shiny, pruritic papules on the skin and milky white 
lesions on the mucosa. Based on the lymphocytic inflam-
matory response, cell-mediated immunity is noted to play 
the major role in triggering the disease. Though the exact 
etiology is still unknown, clinical observations and anec-
dotal evidence point exposure to a number of exogenous 
agents. Up to date viruses, medications and contact aller-
gens have been implicated in the etiopathogenesis (1-5). 
However, there are only a few studies questioning whether 
there is any alteration in contact hypersensitivity response 
in these patients. A literature survey displayed that contact 
hypersensitivity to standard allergens has been checked 
out in oral LP, but not in cutaneous LP before (6). 
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papules, and a strong positive reaction was indicated if 
there are vesicles in addition to the lesions listed above.
Fisher’s exact test was used for statistical analysis. A p va-
lue of 0.05 was defined as the level of significance.
Results
After withdrawals due to noncompliance with the ins-
tructions during either test procedure or reading period, 
43 biopsy proven cutaneous LP patients (28 women, 15 
men) age range 19 to 68 years, (mean 44) and 33 controls 
(21 women, 12 men) age range 18 to 68, (mean 43.2) were 
evaluated in this study. Of the 43 LP cases 30 were genera-
lized LP, 8 were localized LP, 3 were lichen hypertrophicus, 
and the remaining two were cases of a lichen planopilaris 
and a lichen planus pemphigoides. In the patient group 
the duration of the disease ranged from 1 week to 5 years 
(mean 9.6 months), mucosal involvement was present in 
32.5% (14/43) of the patients. During testing, active lesi-
ons were recorded in 62.7% (27/43) of the patients. Of the 
43 patients 19 (44%) did not take any treatment before 
patch testing, while the other 23 were on either syste-
mic or topical therapy. Among the 23 patients, 7 had had 
completed enoxaparin treatment before testing with an 
average of 6.4 months (range 4-9.5 months); 6 had rece-
ived metronidazole and stopped treatment with a mean 
of 66.6 days ago (range 3 days-3.5 months). A total of 8 
who had been on topical corticosteroids had given up 
therapy more than 2 weeks ago, a patient who had been 
given systemic steroids had completed the therapy one 
month ago. The last case had completed a course of PUVA 
treatment 6 months ago. 
In the LP group a positive patch test reaction was found 
in 11.6% (5/43) of the patients. These were found to be 
nickel sulphate in 2 patients, which were weak positive, 
cobalt chloride in 2 patients that were both strong positi-
ve and formaldehyde in the last one with a weak positive 
reaction. One of the patients was known to be allergic to 
nickel before the test and one of the cobalt positive pa-
tients was involved as a manufacturer in the automotive 
sector. Other patients did not give a history clarifying the 
positive patch test reactions. 
In the control group 10 of the 33 cases were using some 
kind of treatment including antiinflammatories, muscle 
relaxants, antibiotics, antihypertensives, thyroid hormo-
nes, vitamins, antidepressants which have not been fo-
und to have a notorious effect on contact hypersensitivity 
reactions. As a result, 30.3% (10 of the 33) of the controls 
In this study, it is aimed to investigate the prevalence of 
hypersensitivity to standard contact allergens in cutane-
ous LP patients and to contribute to the discussions on 
studies examining the causal relationship in between two 
entities..
Material and methods
In the present study 50 consecutive cutaneous LP patients 
who were treated at the dermatology clinic and 40 age 
and sex matched controls at the physical therapy and re-
habilitation ward treated for sports injuries, spinal disco-
pathies, fractures and who were free of any inflammatory 
dermatologic lesions, were patch tested with T.R.U.E. Test 
methodology. (Pharmacia & Upjohn Hillerod AS, Hillerod, 
Denmark) Patients with a diagnosis of connective tissue 
disease and inflammatory dermatologic diseases were 
not included in the control group. Verbal informed con-
sent was taken from all the participants. All enrolled pa-
tients had histologically proven LP and both the patients 
and the controls were questioned and examined before 
test procedure. Type of LP, the duration of the disease, 
the presence of mucosal involvement and active lesions, 
previous treatments before testing, dental amalgams and 
metal prostheses if present, were recorded. 
T.R.U.E. Test is a ready-to-use patch test system for diag-
nosis of allergic contact dermatitis containing individual 
allergens or allergen mixes released onto the skin after 
applying the patches (7). The T.R.U.E. Test panels used in 
this study contained 24 allergens (12 in each); consisting 
of nickel sulphate, wool alcohols, neomycin sulphate, po-
tassium dichromate, caine mix, fragrance mix, colophony, 
epoxy resin, quinoline mix, balsam of Peru, ethylenedia-
mine dihydrochloride, cobalt chloride, p-tert-butylphenol 
formaldehyde resin, paraben mix, carba mix, black rubber 
mix, Cl+Me-isothiazolinone, quarternium-15, mercapto-
benzothiazole, p-phenylenediamine, formaldehyde, mer-
capto mix, thiomersal and thiuram mix.
Since steroids may suppress a positive test reaction, pati-
ents on systemic or topical steroids within previous 2 we-
eks were excluded from the study. The tests were applied, 
only to healthy skin to prevent misinterpretation of the 
test results. Patients returned for reading the patch test 
results at the 48th and 96th hours after the application. 
The interpretation was made according to the following 
description. A doubtful reaction was interpreted if there is 
only faint macular erythema, a weak positive reaction was 
recorded if there are erythema, infiltration and possible 
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was found to have positive patch test reactions. These 
were nickel sulphate in 3 cases, wool alcohols and para-
ben mix together in one case, Cl+Me-Isothiazolinone in 2 
cases and colophony, thiomersal, potassium dichromate, 
epoxy resin each in one patient. All the patch test reacti-
ons were weak positive except 3 strong positives of nickel 
sulphate, epoxy resin and thiomersal in sequence. Among 
10 patch test positive controls 3 gave a history relevant 
of the clinical reaction. Dental metal compounds were fo-
und in 62.7% (27/43) of the LP patients while it was 46.1% 
(12/26) in the control group. The difference between the 
two was not significant (p=0.21). 
Discussion
In this study a positive patch test reaction was found in 
11.6% of the LP patients while the control group showed 
a percentage of 30.3%. The positive patch test reaction of 
11.6% which was presumed to show a difference at first 
sight did not result in a statistically significant variation to 
be considered under scrutiny. (p= 0.0787). 
Standard screening series test only statistically frequent 
allergens that have been implicated in the etiology of al-
lergic contact dermatitis. Since there have been reports of 
LP implicating contact with certain substances including 
color film developers, latex antioxidant, epoxy resin, nic-
kel salts, copper, mercury and metacrylic acid esters and 
dental metal compounds (2-5,8,9), a higher rate of patch 
test positivity could be assumed among these patients. In 
this respect, there is just one study arguing for decreased 
delayed type hypersensitivity response to dinitrochloro-
benzene in 17 typical LP patients. Furthermore, the aut-
hors of this study suggested a primary immune defect in 
this group of patients (10). Our results showed that dela-
yed type hypersensitivity response was same as the cont-
rol group which is a totally different result from the latter 
study. 
The patch test positivity of 30.3% found in the control 
group is in accordance with rates reported in general po-
pulations from different countries. Unfortunately, as stan-
dard patch test screening in general Turkish population 
is not available, we could only compare our results with 
that obtained from predetermined patient populations. 
In a retrospective study comprising 3017 adult patients, 
Ertam et al. found a patch test positivity of 31.3% (11) whi-
le in a pediatric population of 360, Önder et al. obtained 
a result of 32% (12). However, it should be noted that in 
both of these studies, the individuals had a pre-diagnosis 
of contact dermatitis and the numbers should be lower in 
the general population. Anyway studies on the prevalen-
ce of contact sensitization in the general population from 
Germany and Australia also showed high frequencies of 
40% and 35% respectively (8,13). It is known that the pre-
valence of patch test positivity increases with age even in 
the absence of dermatitis (14). The mean age was about 
44 in our study, compatible with the aforementioned sta-
tement. Comparison of relevant sensitivities was also si-
milar in these two groups.
The patch test is a biologic test and like any other such 
test has the potential of some interpretation errors. The 
drugs that have been used during testing period may al-
ter the contact hypersensitivity reaction. In this study 20 
of the 43 LP patients had not been given any drugs while 
23 had taken some treatment namely enoxaparin (n=7), 
metronidazole (n=6), topical steroids (n=8), systemic 
steroids (n=1), and PUVA (n=1). Apart from steroids and 
PUVA, enoxaparin and metronidazole are known to cause 
inhibition of contact hypersensitivity (15-17). In our pati-
ent group the duration between completion of the treat-
ments and the test was sufficient to remove the effects of 
the drugs. Furthermore, the timing of the patch test with 
respect to disease activity is another important factor mo-
difying the results. In other words, the chance of getting 
a positive response increases in active disease (18). In our 
patients active LP lesions were present in 62.7% while the 
positive patch test reaction was only 11.6%. It is thought 
that the activity of the disease in the majority of our pati-
ents is a favorable condition for examining a possible inte-
raction between either positive or negative. 
In conclusion, this is the first study questioning the pre-
valence of delayed type hypersensitivity against standard 
patch test allergens in cutaneous LP and it was shown to 
be 11.6%. Contrary to the concepts so far, our data indica-
ted that in cutaneous LP contact hypersensitivity respon-
se does not seem to change. Finally, we are aware of the 
need for further research in larger study groups to draw 
reliable and firm conclusions. 
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